Tazarotene Dosage and Treatment Regimen
For the treatment of acne vulgaris and plaque psoriasis, tazarotene should be applied as a thin film once daily in the evening to affected areas only. 1
Dosing Guidelines
For Acne Vulgaris:
- Apply a thin layer (2 mg/cm²) of tazarotene 0.1% cream once daily in the evening to the skin areas where acne lesions appear 1
- Cleanse the face gently and ensure skin is completely dry before application 1
- Use enough to cover the entire affected area 1
- Safety and effectiveness have not been established in pediatric patients under 12 years of age 2
For Plaque Psoriasis:
- Apply a thin film (2 mg/cm²) of tazarotene 0.1% cream once daily in the evening to cover only the psoriatic lesions 1
- If a bath or shower is taken prior to application, ensure the skin is completely dry before applying the cream 1
- If emollients are used, they should be applied at least one hour before application of tazarotene cream 1
- Avoid application to unaffected skin, as it may be more susceptible to irritation 1
Combination Therapy Recommendations
For Psoriasis:
- The combination of tazarotene with medium- or high-potency topical corticosteroids for 8-16 weeks is more effective than tazarotene monotherapy and is recommended for the treatment of mild to moderate psoriasis (strength of recommendation: A) 2
- This combination therapy increases efficacy while reducing local adverse events 2
- The combination also increases the duration of treatment effect and extends remission time 2
For Nail Psoriasis:
- Tazarotene 0.1% cream can be used for nail psoriasis, particularly when applied under occlusion 3
- Has shown significant improvement in the Nail Psoriasis Severity Index with respect to onycholysis, pitting, hyperkeratosis, and oil spots 2
Managing Side Effects
- Common adverse effects include pruritus, burning, skin redness, peeling, desquamation, dry skin, and erythema 2, 4
- Side effects are most common during the first 1-2 weeks of therapy 4
- To minimize irritation:
Important Precautions
- Pregnancy category X: Tazarotene is contraindicated during pregnancy 2
- Women of childbearing potential should have a negative pregnancy test within 2 weeks prior to starting treatment 1
- Therapy should begin during a menstrual period 1
- Avoid exposure to sunlight, sunlamps, and weather extremes; wear sunscreen daily 2, 1
- Not for ophthalmic, oral, or intravaginal use 1
- If contact with eyes occurs, rinse thoroughly with water 1
Pharmacokinetics
- Tazarotene is rapidly hydrolyzed by esterases to its active metabolite, tazarotenic acid 5
- Systemic bioavailability is low (approximately 1% in healthy skin, up to 5% in psoriatic skin) 5
- Steady-state concentrations are achieved within 2 weeks of topical treatment 5
- The drug is rapidly eliminated via urinary and fecal pathways with a terminal half-life of about 18 hours 5
Treatment Duration
- For acne, if there is no improvement after 12 weeks, treatment should be reassessed 6, 7
- For psoriasis, clinical trials have shown significant improvement with 12 weeks of treatment 8
By following these dosing guidelines and taking appropriate precautions, tazarotene can be an effective treatment for both acne vulgaris and plaque psoriasis.